Skip to Content

Philips recall: AASM calls for support from CMS, payers

Philips recall: AASM calls for support from CMS, payers

DARIEN, Ill. – The American Academy of Sleep Medicine and other professional organizations are making the case to CMS and private payers that the 90-day adherence rule for PAP therapy should be temporarily suspended in the wake of the Philips recall. 

“Given that many patients will be affected by the recall, we are requesting support from CMS and private payers to temporarily suspend the 90-day adherence rule to allow patients to have existing equipment repaired or receive new equipment from DME suppliers,” the letter states. 

The American Academy of Neurology, the American College of Chest Physicians, the American Thoracic Society, the Alliance of Sleep Apnea Partners and the American Sleep Apnea Association joined the AASM in sending the letter to CMS and private payers. 

The groups also make the case for CMS making an exception to the RUL requirements for the equipment repairs or replacements that will result from the recall. 

“Our societies believe that it is both reasonable and necessary to allow DME suppliers to repair or replace the recalled equipment without requiring documentation of a new clinical evaluation, sleep test or trial period, and do not think patients should be responsible for the repair or replacement costs,” the letter states. 

To read the letter to CMS in full, go here

To ready the letter to private payers, go here


To comment on this post, please log in to your account or set up an account now.